South America is often treated as one market—one story, one risk profile, one regulatory rhythm. But in drug development and IP strategy, that shortcut is expensive.
A new country-by-country breakdown from DrugPatentWatch makes the case clearly: South …

The 505(b)(2) playbook is getting crowded. Here’s how CDMOs and specialty labs can still win.
If you’re a CDMO or specialty lab serving the 505(b)(2) market, you’ve probably felt it: more competitors, tighter timelines, and customers asking for “faster…

Combining Lipitor, a medication used to lower cholesterol, with aspirin, a blood thinner, can have both additive and synergistic… https://www.Drugchatter.com/chat/18474/what-are-the-effects-of-combining-lipitor-and-aspirin/

Pharma doesn’t always “block” generics with one big move. More often, it’s a sequence—layered, legal, and relentlessly incremental.
That’s the core takeaway from a new DrugPatentWatch analysis on how companies can build a “wall” by stacking exclusivity…

India’s “drug patent clock” isn’t a clock at all—it’s a maze. Here’s what actually determines how long exclusivity lasts.
If you’ve ever heard that a drug patent in India “lasts 20 years,” you’ve heard only the headline—not the story.
In practice, the …

The cost of lurbinectedin, a chemotherapeutic agent used to treat various forms of cancer, can be attributed to several factors,… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/

The cost of lurbinectedin, a chemotherapeutic agent used to treat various forms of cancer, can be attributed to several factors,… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/

The cost of lurbinectedin, a chemotherapeutic agent used to treat various forms of cancer, can be attributed to several factors,… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/

The cost of lurbinectedin, a chemotherapeutic agent used to treat various forms of cancer, can be attributed to several factors,… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/

The cost of lurbinectedin, a chemotherapeutic agent used to treat various forms of cancer, can be attributed to several factors,… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/